Patents by Inventor Wolfgang Morick

Wolfgang Morick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for use as a laxative
    Patent number: 7611736
    Abstract: The invention relates to a pharmaceutical composition which is suitable in particular for use as purgative (cathartic), where the composition comprises in combination and in each case in pharmaceutically effective amounts (A) senna fruit dry extract and (B) plantago seeds (plantaginis ovatae semen). The composition can advantageously be manufactured by fluidized bed granulation. The composition is in particular free of guar gum, is dust-free, is dispersible in water and has a pleasant taste and can be supplemented straightforwardly with vitamins, minerals, trace elements and the like.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: November 3, 2009
    Assignee: Madaus GmbH
    Inventors: Wolfgang Morick, Lars-Norbert Prenner, Michael Hubbert, Kurt Gebhart, Wolf Behm
  • PHARMACEUTICAL COMPOSITION FOR USE AS A LAXATIVE
    Publication number: 20090186106
    Abstract: The invention relates to a pharmaceutical composition which is suitable in particular for use as purgative (cathartic), where the composition comprises in combination and in each case in pharmaceutically effective amounts (A) senna fruit dry extract and (B) plantago seeds (plantaginis ovatae semen). The composition can advantageously be manufactured by fluidized bed granulation. The composition is in particular free of guar gum, is dust-free, is dispersible in water and has a pleasant taste and can be supplemented straightforwardly with vitamins, minerals, trace elements and the like.
    Type: Application
    Filed: April 8, 2009
    Publication date: July 23, 2009
    Applicant: Madaus GmbH
    Inventors: Wolfgang Morick, Lars-Norbert Prenner, Michael Hubbert, Kurt N. Gebhart, Wolf Behm
  • Pharmaceutical Composition for Use as a Laxative
    Publication number: 20090110759
    Abstract: The invention relates to a pharmaceutical composition which is suitable in particular for use as purgative (cathartic), where the composition comprises in combination and in each case in pharmaceutically effective amounts (A) senna fruit dry extract and (B) plantago seeds (plantaginis ovatae semen). The composition can advantageously be manufactured by fluidized bed granulation. The composition is in particular free of guar gum, is dust-free, is dispersible in water and has a pleasant taste and can be supplemented straightforwardly with vitamins, minerals, trace elements and the like.
    Type: Application
    Filed: June 16, 2008
    Publication date: April 30, 2009
    Applicant: Madaus GmbH
    Inventors: Wolfgang Morick, Lars-Norbert Prenner, Michael Hubbert, Kurt N. Gebhart, Wolf Behm
  • PHARMACEUTICAL COMPOSITION FOR USE AS A LAXATIVE
    Publication number: 20080311210
    Abstract: The invention relates to a pharmaceutical composition which is suitable in particular for use as purgative (cathartic), where the composition comprises in combination and in each case in pharmaceutically effective amounts (A) senna fruit dry extract and (B) plantago seeds (plantaginis ovatae semen). The composition can advantageously be manufactured by fluidized bed granulation. The composition is in particular free of guar gum, is dust-free, is dispersible in water and has a pleasant taste and can be supplemented straightforwardly with vitamins, minerals, trace elements and the like.
    Type: Application
    Filed: February 29, 2008
    Publication date: December 18, 2008
    Applicant: Madaus GmbH
    Inventors: Wolfgang Morick, Lars-Norbert Prenner, Michael Hubbert, Kurt N. Gebhart, Wolf Behm
  • Stable mitoxantrone solutions
    Patent number: 6143795
    Abstract: An aqueous solution of from about 1 mg/ml to about 5 mg/ml mitoxantrone.HCl, from about 0.01% wt. to about 0.15% wt. based on the solution of sodium edetate, sodium chloride, sodium acetate, and acetic acid, and a process for preparing the same.
    Type: Grant
    Filed: April 26, 1999
    Date of Patent: November 7, 2000
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Katrin Moschner, Mario Weingart, Michael Pieroth, Wolfgang Morick, Elisabeth Wolf-Heuss
  • Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect
    Patent number: 6017909
    Abstract: Salts of azelastine with acetic acid, gluconic acid, lactic acid or malic acid.
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: January 25, 2000
    Assignee: Asta Pharma AG
    Inventors: Helmut Hettche, Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick
  • Salts of azelastine having improved solubility useful at providing a cytoprotective effect
    Patent number: 5998403
    Abstract: The present invention relates to salts of azelastine having improved solubility in water. The salts of the present invention are prepared by reacting azelastine with acetic acid, gluconic acid, lactic acid, or malic acid. The azelastine salts are effective in providing a cytoprotective effect.
    Type: Grant
    Filed: July 28, 1998
    Date of Patent: December 7, 1999
    Assignee: Asta Pharma Aktiengesellschaft
    Inventors: Helmut Hettche, Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick
  • Salts of azelastine having improved solubility
    Patent number: 5859003
    Abstract: The present invention relates to salts of azelastine having improved solubility in water. The salts of the present invention are prepared by reacting azelastine with acetic acid, gluconic acid, lactic acid or malic acid. A pharmaceutical composition may be prepared containing an azelastine salt and a pharmaceutically-acceptable carrier or diluent therefor. The pharmaceutical composition is useful in the treatment of allergies, asthma, inflammatory and psoriasis disorders and provides a cytoprotective effect.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: January 12, 1999
    Assignee: Asta Pharma Aktiengesellschaft
    Inventors: Helmut Hettche, Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick
  • Method of treating inflammatory disorders and psoriasis with salts of azelastine
    Patent number: 5086050
    Abstract: Salts of azelastine with acetic acid, gluconic acid, lactic acid or malic acid.
    Type: Grant
    Filed: February 8, 1991
    Date of Patent: February 4, 1992
    Assignee: Asta Pharma AG
    Inventors: Helmut Hettche, Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick